Search
Close this search box.
Search
Close this search box.

English

ApplyBoard Launches Abbie, the World’s First AI Advisor for Studying Abroad

Powered by GPT, Abbie offers personalized expert guidance to support and streamline the entire international education journey Kitchener, Ontario, Canada, June 18, 2024 (GLOBE NEWSWIRE) — ApplyBoard, the leading international student mobility platform, today announced the launch of Abbie, an industry-first AI advisor designed to revolutionize the study abroad experience.

Global Center on Adaptation and AUDA-NEPAD Sign Memorandum of Understanding to Accelerate Climate Change Adaptation in Africa

Rotterdam, June 14, 2024 (GLOBE NEWSWIRE) — The Global Center on Adaptation (GCA) and the African Union Development Agency (AUDA-NEPAD) signed a landmark memorandum of understanding (MoU) to collaborate on accelerating climate change adaptation efforts across Africa. Building on the AUC-GCA-AfDB Africa-led, Africa-owned Africa Adaptation Acceleration Program (AAAP), the partnership

From Awareness to Action on Global Fatty Liver Day

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores

Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

ADALVO LIMITED Anil Okay, Adalvo CEO, expresses his thoughts on this milestone SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza® pre-filled pen, indicated

Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

ADALVO LIMITED Anil Okay, Adalvo CEO, expresses his thoughts on this milestone SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza® pre-filled pen, indicated

Nikkiso Clean Energy & Industrial Gases Group Announces CEO Transition July 1, 2024

TEMECULA, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE: 6376), announced today after a Board vote, that effective July 1, 2024, Adrian Ridge will succeed Peter Wagner as Nikkiso Clean Energy & Industrial Gases Group’s (part of Nikkiso’s Industrial Division) as Chief Executive Officer. Wagner will stay